Medicines Substances Companies Statistics

A free, open platform for EU medicines data, based on official EMA data.

Database

Medicines
Substances
Companies

Data Sources

EMA

2026 uMedical - Open Source Project

Imprint
Privacy Policy
Terms
Contact

Teriparatide Cinnagen

Application withdrawnHuman

Biosimilar

Details

EMA number	EMEA/H/C/005543
ATC code	H05AA02
Authorisation	-
Revision	-

Therapeutic indication

Treatment of osteoporosis

MeSH: Osteoporosis;Osteoporosis, Postmenopausal

Group: Calcium homeostasis

Active substances

Marketing Authorisation Holder

CinnaGen Co Unipessoal LDA

Teriparatide Cinnagen | uMedical